IO Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	98	124	66	184	-	-
Market Cap Growth	-	86.88%	-64.06%	-	-	-
Enterprise Value	-39	-17	-74	-27	-3	1
PE Ratio	-1.44	-1.44	-0.93	-2.46	-	-
PB Ratio	0.77	0.93	0.48	0.87	-	-
P/FCF Ratio	-1.72	-1.72	-1.10	-4.52	-	-
P/OCF Ratio	-1.73	-1.73	-1.11	-4.54	-	-
EV/EBITDA Ratio	0.20	0.20	1.06	0.40	0.28	-0.08
EV/EBIT Ratio	0.20	0.20	1.05	0.40	0.28	-0.08
EV/FCF Ratio	0.23	0.23	1.22	0.66	0.34	-0.09
Debt / Equity Ratio	0.02	0.02	0.02	-	-	-0.37
Debt / EBITDA Ratio	-0.03	-0.03	-0.04	-	-	-0.81
Debt / FCF Ratio	-0.03	-0.03	-0.05	-	-	-0.97
Quick Ratio	9.11	9.11	13.36	20.53	1.12	0.72
Current Ratio	9.37	9.37	13.88	21.52	1.85	0.87
Interest Coverage	-	-	-231.40	-186.84	-462.15	-1789.50
Return on Equity (ROE)	-66.30%	-66.30%	-43.40%	-84.90%	49.60%	-
Return on Assets (ROA)	-59.60%	-59.60%	-40.90%	-65.80%	-193.60%	-
Return on Capital (ROIC)	-67.41%	-67.41%	-50.43%	-19.46%	28.74%	66.67%
Earnings Yield	-84.30%	-69.50%	-107.82%	-40.66%	-	-
FCF Yield	-70.57%	-58.18%	-91.16%	-22.12%	-	-
Buyback Yield / Dilution	-51.10%	-51.10%	-564.62%	-2346.74%	-	-
Total Shareholder Return	-51.10%	-51.10%	-564.62%	-2346.74%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).